Phathom Pharmaceuticals Ownership | Who Owns Phathom Pharmaceuticals?
Phathom Pharmaceuticals Ownership Summary
Phathom Pharmaceuticals is owned by 112.40% institutional investors, 7.70% insiders. Frazier life sciences management is the largest institutional shareholder, holding 17.32% of PHAT shares. Invesco OFI Global Equity is the top mutual fund, with 2.89% of its assets in Phathom Pharmaceuticals shares.
PHAT Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Phathom Pharmaceuticals | 112.40% | 7.70% | -20.09% |
| Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
| Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Frazier life sciences management | 10.11M | 17.32% | $104.13M |
| Medicxi ventures management (jersey) | 7.46M | 12.79% | $76.89M |
| Carlyle group | 3.50M | 5.99% | $35.84M |
| Invesco | 3.14M | 5.39% | $32.38M |
| Blackrock | 2.93M | 5.01% | $30.14M |
| Jennison associates | 2.76M | 4.72% | $28.40M |
| Ensign peak advisors | 2.24M | 3.85% | $23.12M |
| Vanguard group | 2.21M | 3.79% | $22.78M |
| Nea management company | 1.96M | 3.36% | $20.19M |
| Avidity partners management lp | 1.62M | 2.78% | $16.69M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Medicxi ventures management (jersey) | 7.46M | 22.93% | $76.89M |
| Propel bio management | 869.93K | 5.81% | $8.96M |
| Catalys pacific | 721.96K | 5.61% | $7.44M |
| Checkpoint capital | 875.00K | 5.43% | $9.01M |
| Frazier life sciences management | 10.11M | 4.87% | $104.13M |
| Carlyle group | 3.50M | 3.40% | $35.84M |
| Decheng capital | 850.00K | 2.68% | $8.76M |
| Saturn v capital management | 593.31K | 2.31% | $6.11M |
| Oracle investment management | 225.00K | 2.16% | $2.32M |
| Ghost tree capital | 600.00K | 1.94% | $6.18M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Portolan capital management | 1.13M | 0.96% | 1.13M |
| Jennison associates | 2.76M | 0.02% | 1.11M |
| Morgan stanley | 762.60K | 0.00% | 525.44K |
| Gilder gagnon howe | 1.47M | 0.19% | 454.64K |
| Checkpoint capital | 875.00K | 5.43% | 429.84K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Octagon capital advisors lp | - | - | -455.00K |
| 683 capital management | 1.40M | 1.09% | -250.00K |
| Millennium management | - | - | -225.02K |
| Newtyn management | - | - | -165.00K |
| Two sigma investments, lp | 303.43K | 0.01% | -164.02K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Portolan capital management | 1.13M | 0.96% | 1.13M | $11.64M |
| Prudential financial | 352.34K | 0.01% | 352.34K | $3.63M |
| Oracle investment management | 225.00K | 2.16% | 225.00K | $2.32M |
| Mml investors services | 19.60K | 0.00% | 19.60K | $202.00K |
| Corebridge financial | 18.36K | 0.00% | 18.36K | $189.09K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -7.00 |
| Bessemer group | -325.00 |
| Aquatic capital management | -500.00 |
| Vestcor | -548.00 |
| Ica group wealth management | -1.30K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 138 | 18.97% | 72,638,512 | 28.44% | 112 | 1.21% | 85 | 28.79% | 20 | - |
| Jun 30, 2024 | 115 | -1.71% | 56,555,159 | 8.24% | 96 | 1.17% | 66 | 24.53% | 19 | -44.12% |
| Mar 31, 2024 | 117 | -2.50% | 52,249,167 | 11.99% | 91 | 1.35% | 53 | -28.38% | 34 | 47.83% |
| Dec 31, 2023 | 120 | 6.19% | 46,653,575 | 6.61% | 82 | 1.01% | 74 | 17.46% | 23 | -4.17% |
| Sep 30, 2023 | 113 | 4.63% | 43,760,270 | 2.29% | 90 | 0.88% | 63 | -7.35% | 24 | 20.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Invesco OFI Global Equity | 1.98M | 2.89% | 252.08K |
| Invesco Global A | 1.98M | 2.89% | - |
| Jennison Health Sciences Equity | 1.97M | 2.89% | 482.19K |
| PGIM Jennison Health Sciences Z | 1.97M | 2.89% | - |
| Vanguard Total Stock Mkt Idx Inv | 1.65M | 2.41% | 2.38K |
| Strategic Advisers U.S. Total Stock{mg} | 1.48M | 2.16% | -273.72K |
| PGIM Jennison Small Company A | 1.42M | 2.08% | 560.99K |
| Fidelity Select Biotechnology | 1.30M | 1.91% | 1.30M |
| Strategic Advisers Small-Mid Cap | 1.24M | 1.82% | 278.88K |
| iShares Russell 2000 ETF | 876.30K | 1.28% | -1.97K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 13, 2024 | KARBE FRANK | - | Buy | $99.08K |
| Dec 13, 2024 | Parikh Asit | - | Buy | $81.25K |
| Jul 15, 2024 | Nabulsi Azmi | Chief Operating Officer | Sell | $127.76K |
| Jul 15, 2024 | Henderson Molly | CFO and CBO | Sell | $50.69K |
| Jul 15, 2024 | Curran Terrie | President and Chief Executive | Sell | $396.70K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q3 | - | 3 |
| 2024 Q2 | - | 1 |
| 2024 Q1 | - | 3 |
| 2023 Q4 | 3 | 3 |
| 2023 Q3 | - | - |
PHAT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools